Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial.

J Michael Wells,Gerard J Criner,David M G Halpin,MeiLan K Han,Renu Jain,Peter Lange,David A Lipson,Fernando J Martinez,Dawn Midwinter,Dave Singh,Robert A Wise

Chronic obstructive pulmonary diseases (Miami, Fla.)（2023）

引用 3|浏览29

暂无评分

摘要

Results confirm a substantial mortality risk during severe exacerbations, and an underlying CV risk. FF/UMEC/VI significantly reduced the risk of a composite cardiopulmonary AE versus UMEC/VI.

查看译文

关键词

cardiovascular diseases,chronic obstructive,pneumonia,pulmonary disease,respiratory therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要